CD4^+CD25^+调节性T细胞与肿瘤关系研究概况
被引量:1
摘要
1995年,Sakaguchi等发现了CD4+CD25+调节性T细胞(CD4+CD25+Tr)。近年来有关CD4+CD25+Tr细胞的研究日益广泛和深入,其在肿瘤的相关研究中也越来越受到关注,国内外的研究报道都在不断涌现,现将相关报道综述如下。
出处
《右江民族医学院学报》
2011年第4期515-517,共3页
Journal of Youjiang Medical University for Nationalities
参考文献16
-
1Kawahata K, Misaki Y, Yamauchi M, et al. Generation of CD4( + ) CD25 ( + ) regulaotry T cells from autoraective Tcells imultaneously with their negative selection in the thymus and form nonautoraective T cells by endogenous TCR expression [J]. J lmmunol,2006,168(9) :4399 - 4405.
-
2Paust S, Cantor H. Regulatory T cells and autoimmune dis- ease [J ]. Immunol Rev,2005,204 : 195 - 207.
-
3高琦,马湉,张霞,姜杨,张利宁.CD4^+ CD25^+ Foxp3^+及CD4^+ CD25^- Foxp^(3+)调节性T细胞在小鼠衰老过程中的变化规律[J].山东大学学报(医学版),2008,46(10):927-930. 被引量:2
-
4Cureil TJ, Coukos G, Zou L, et al. specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privi- lege and predicts reduced survival [J]. Nat Med, 2004, 10 (9) :942 - 949.
-
5雷晓,余佩武,赵永亮,石彦,饶芸,曾冬竹,吴淼,周立新.CD4^+CD25^+调节性T细胞在胃癌患者的表达及其临床意义[J].第三军医大学学报,2006,28(5):397-400. 被引量:9
-
6Sehabowsky RH, Madireddi S, Sharma R, et al. Targeting CD4+ CD25 + FoxP3 + regulatory T - cells for the augmenta-tion of cancer immunotherapy [ J ]. Curr Opin Investig Drugs,2007,8(12) :1002 - 1008.
-
7Gregor PD, Wolchok JD, Ferrone CR, et al. CTLA- 4 blockade in combination with xenogeneic DNA vaccines en-hances T - cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems [ J ]. Vaccine,2004,22(13 - 14) :1700 - 1708.
-
8Yu P, Lee Y, Liu W, et al. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late- stage tumors [J]. J Exp Med,2005,201(5) :779 - 791.
-
9Prasad SJ, Farrand K J, Matthews SA, et al. Dendritic cells loaded with stressed tumor cells elicit long- lasting protective tumor immunity in mice depleted of CD4 + CD25 + regulatory T cdls [J]. J Immunol,2005,174(1) :90 - 98.
-
10Grauer OM. CD4 + Foxp3- regulatory T cells, gradually ac- cumulate in gliomas during tumor growth and efficiently suppress antiglioltna immune responses in vivo [J ]. Int J Cancer, 2007,121 ( 1 ) :95 - 105.
二级参考文献34
-
1Wing K, Ekmark A, Karlsson H, et al. Characterization of human CD25 + CD4 + T cells in thymus, cord and adult blood[ J]. Immunology, 2002, 106(2) : 190-199.
-
2Karube K, Ohshima K. Expression of Foxp3, a key molecule in CD4 + CD25 + regulatory T ceils, in adult T-cell leukaemia/ lymphoma cells. Br J Haematol, 2004, 126(1) :81-84.
-
3Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells [J]. Nat Immunol, 2003, 4(4):330-336.
-
4Miller R A. The aging immune system: primer and prospectus [J]. Science, 1996, 273(5271):70-74.
-
5Hirokawa K, Utsuyama M, Kasai M, et al. Understanding the mechanism of the age-change of thymic function to promote T cell differentiation[J]. Immunol Lett, 1994, 40(3) :269-277.
-
6Haynes L, Eaton S M, Swain S L. Effect of age on naive CD4 responses: impact on effector generation and memory development. Springer Semin[ J]. Immunopathology, 2002, 24(1) : 53-60.
-
7SAKAGUCHI S, SAKAGUCHI N, ASANO M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[ J ]. J Immunol, 1995, 155(3): 1151-1164.
-
8BAECHER-ALLAN C, BROWN J A, FREEMAN G J, et al. CD4^+CD25 high regulatory cells in human peripheral blood[J]. J Immunol,2001, 167(3) : 1245 - 1253.
-
9FUJIO K, OKAMOTO A, TAHARA H, et al. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease[J]. J Immunol, 2004, 173(3) : 2118 -2125.
-
10MAKITA S, KANAI T, OSHIMA S, et al. CD4 + CD25bfight T cellsin human intestinal lamina pmpria as regulatory cells[J]. J Immunol,2004, 173(5): 3119-3130.
共引文献30
-
1张平雨,王嘉军.CD4^+ CD25^+调节性T细胞与肿瘤免疫的研究进展[J].微生物学免疫学进展,2011,39(3):82-84.
-
2施晓琴,刘军权,陈复兴,陈维峰.自身树突状细胞疫苗治疗尖锐湿疣的临床研究[J].中国肿瘤生物治疗杂志,2007,14(3):275-278.
-
3彭启全,李升平,徐立,李锦清.117例肝癌患者外周血调节T细胞水平及其临床意义[J].癌症,2007,26(7):748-751. 被引量:18
-
4曾冬竹,余佩武,雷晓,石彦,王自强,郑峻松.CD4^+ CD25^+调控T细胞对小鼠胃癌的影响[J].中华胃肠外科杂志,2007,10(4):368-371. 被引量:7
-
5瞿利帅,陈世耀.CD4^+CD25^+调节性T细胞对胃癌免疫调节的作用[J].现代消化及介入诊疗,2007,12(4):263-265. 被引量:3
-
6李丽.CD4^+CD25^+调节性T细胞在肿瘤免疫中的意义及研究进展[J].华北国防医药,2008,20(3):74-76. 被引量:2
-
7王晶桐,张媛媛,彭涛,王妍,姚建,张姗姗,武将,刘玉兰.胃癌患者外周血调节性T细胞的变化及其意义[J].中华普通外科杂志,2008,23(11):850-852. 被引量:1
-
8史红鱼,王桂琴.CD_4^+ CD_(25)^+调节性T细胞与肿瘤免疫[J].白血病.淋巴瘤,2007,16(6):472-475. 被引量:2
-
9樊慧婷,林洪生,李杰,祁鑫,裴迎霞.Lewis肺癌荷瘤小鼠CD4^+CD25^+Foxp3^+调节性T细胞及髓样抑制细胞与肿瘤生长的关系[J].现代免疫学,2009,29(5):370-375. 被引量:4
-
10蒋小卫,徐曼.重组E.coli LLO/WT1诱导树突状细胞成熟并促进特异性抗肿瘤免疫[J].第四军医大学学报,2009,30(19):1887-1890. 被引量:1
同被引文献33
-
1刘璇,郝敬全,温少瑾.调节性T细胞在肿瘤免疫和肿瘤免疫治疗中的作用[J].医学信息(医学与计算机应用),2014,0(13):491-491. 被引量:1
-
2Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunolog- ic tolerance maintained by CD25^+ CD4^+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance [ J ]. Immu- nol Reviews, 2001,182(1) :18-32.
-
3Dasgupta A, Saxena R. Regulatory T ceils: a review[ J]. Natl Med J India, 2012,25(6) :341-351.
-
4Hori S, Nomura T, Sakaguchl S. Control of regulatory T cell development by the transcription factor Foxp3 [J ]. Science, 2003,299 (5609) : 1057-1061.
-
5Lopez M, Aguilera R, Prez C, et al. The role of regula- tory Tlymphocytes in the induced immune response medi-ated by bio-logical vaccines [ J ]. Immunobiology, 2006, 211(1-2) :127-136.
-
6Meulmeester E, Ten Dijke P. The dynamic roles of TGF- β in cancer[J]. J Pathol, 2011,223(2) :206-219.
-
7Firmpong Boateng K, van Rooijen N, Geiben Lynn R. Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8^+ Tcell immune response by the cytokine TGF-13 [ J ]. PLoS One, 2010,5(8) :e12281.
-
8Cao X, Cai S F, Fehniger T A, et al. Granzyme B and perforin are important for regulatory T cell mediated sup- pression of tumor clearance [ J ]. Immunity, 2007,27 ( 4 ) : 635 -646.
-
9Li Y Q, Liu F F, Zhang X M, et al. Tumor Secretion of CCL22 Activates Intratumoral Tregs Infiltration and Is In- dependent Prognostic Predictor of Breast Cancer [ J ]. PLoS One, 2013,8(10) :e76379.
-
10Facciabene A, Peng X H, Hagemann l S, et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells [ J ]. Nature, 2011,475 ( 7355 ) :226-230.
-
1赵芳,张睿,刘静,王建华,王娟.DC-CIK疗法联合细胞因子对老年乳腺癌患者外周血CD4^+CD25^+Tr细胞水平和免疫功能的影响[J].中国老年学杂志,2015,35(16):4450-4451. 被引量:7
-
2陈跃华,丁明星,徐卫红,傅晓艳,黄伟.胃癌患者外周血调节性T细胞CD_4^+和CD_(25)^+的检测及意义[J].金华职业技术学院学报,2008,8(6):41-43.
-
3陈伟金,聂力平.CD4^+CD25^+调节性T细胞研究进展[J].亚太传统医药,2013,9(6):62-63.
-
4黄云胜,施志明,丁金芳.益气养阴法对肺癌患者外周血肿瘤免疫逃逸相关因子的影响[J].上海中医药大学学报,2007,21(3):48-51. 被引量:11
-
5秦俭,滕家安,冯国生,陈甲信,陈艳荣.鼻咽癌患者外周血调节性T细胞变化[J].实用肿瘤杂志,2010,25(4):416-418. 被引量:6
-
6丁金芳,施志明.乳岩方对绝经后乳腺癌免疫逃逸干预作用的影响[J].新中医,2012,44(6):126-128.
-
7田春桃,韩利艳.参芪十一味颗粒对晚期原发性非小细胞肺癌疗效及肿瘤免疫逃逸的影响[J].新中医,2011,43(11):75-77. 被引量:9
-
8聂明,唐安洲,黄光武,李剑军,莫武宁.鼻咽癌患者放疗前后外周血EBV-DNA和细胞免疫水平的研究[J].肿瘤防治研究,2011,38(4):380-383. 被引量:4
-
9王海燕,吴晓云,李晓荣,魏丽娜,邱惠麒,朱国战,周媛萍.原因不明性复发性流产淋巴细胞免疫治疗的剂量及疗效研究[J].浙江医学,2013,35(20):1813-1815. 被引量:3